NVDA
NVIDIA Corporation
NVDA has the edge over PGY overall, supported by stronger valuation and stronger modeled upside.
PGY
Pagaya Technologies Ltd.
PGY's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
PGY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
PGY's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
PGY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.5x | $16.87 | — |
| Current | 10x | $16.87 | — |
| Cheap | 12x | $20.59 | +22% |
| Fair | 14x | $23.20 | +38% |
| Expensive | 15x | $26.10 | +55% |
Historical ranges are pointers, not guarantees.
PGY's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
PGY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
PGY has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over PGY on earnings, with more consistent year-over-year improvement.
PGY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.24 | +33% |
| Q3 2026 | $1.69 | +$4.52 |
| Q2 2026 | $1.40 | +$5.39 |
| Q1 2026 | $1.11 | +$6.34 |
| Q4 2025 | $0.93 | +$6.59 |
| Q3 2025 | -$2.83 | -$0.30 |
| Q2 2025 | -$3.99 | -$2.06 |
| Q1 2025 | -$5.23 | -$3.82 |
| Q4 2024 | -$5.66 | -$3.55 |
PGY has returned to profit: it earned $1.69 per share over the past year, after losing money the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over PGY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over PGY on profitability, with a higher operating margin.
PGY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $390.5M | +12% |
| Q2 2026 | $387M | +19% |
| Q1 2026 | $317.9M | +9.6% |
| Q4 2025 | $334.8M | +20% |
| Q3 2025 | $350.2M | +36% |
| Q2 2025 | $326.4M | +30% |
| Q1 2025 | $290M | +18% |
| Q4 2024 | $279.4M | +33% |
PGY's revenue has grown year over year every quarter since early 2021: $390M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +6 points |
| Q2 2026 | 27% | +10 points |
| Q1 2026 | 25% | +8.7 points |
| Q4 2025 | 24% | +12 points |
| Q3 2025 | 23% | +14 points |
| Q2 2025 | 17% | +15 points |
| Q1 2025 | 16% | +13 points |
| Q4 2024 | 11% | +6.3 points |
PGY's operating margin was 29% last quarter, up 6 points from the same quarter a year ago, near the top of its range since 2020.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
PGY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $45.8M | -28% |
| Q2 2026 | $71.3M | +33% |
| Q1 2026 | $40M | +31% |
| Q4 2025 | $76.7M | +173% |
| Q3 2025 | $63.8M | +$69.5M |
| Q2 2025 | $53.6M | +382% |
| Q1 2025 | $30.7M | +100% |
| Q4 2024 | $28.1M | +96% |
PGY generated $234M in free cash flow over the past year, up 33% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over PGY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
PGY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +1.2M shares |
| 1 year | +8.2% | +7.4M shares |
| 3 years | +62% | +37.8M shares |
| 5 years | +510% | +82.3M shares |
PGY has 98M diluted shares, up 8.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over PGY on leverage, with a lower net debt burden relative to earnings.
PGY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 1.4x | Healthy |
PGY's net debt is less than a year of its operating earnings (EBITDA).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
PGY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.3 | Neutral |
| Stochastic | 24.3 | Neutral |
PGY's weekly RSI is 45 (neutral) and its Stochastic is 24 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
PGY PE vs Technology Sector
| Metric | PGY | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 28x | 64% below |
| PE % | 0 | 42 | 42 pts below |
PGY has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
PGY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.0 | 6.1% below |
| 20 week MA | $19.1 | 12% below |
| 50 week MA | $17.4 | 2.8% below |
| 100 week MA | $18.8 | 10% below |
| 200 week MA | $16.7 | 1.1% above |
PGY has fallen below most of its moving averages, though it's still 1.1% above its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over PGY on returns for 2026, with the stronger performance.
PGY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $117.2 | $118.7 | +1.2% |
| 2022 | $118.7 | $10.1 | -92% |
| 2023 | $10.1 | $16.6 | +65% |
| 2024 | $16.6 | $9.65 | -42% |
| 2025 | $9.65 | $21.9 | +126% |
| 2026 YTD | $21.9 | $16.9 | -23% |
PGY's yearly returns have swung widely, from +126% in 2025 to −92% in 2022. It's down 23% so far in 2026.